Rongcheng Luo相关文献与解析，生知库 | 链接生命科学的每一步

EFTUD2 maintains the survival of tumor cells and promotes hepatocellular carcinoma progression via the activation of STAT3

EFTUD2 通过激活 STAT3 来维持肿瘤细胞的存活并促进肝细胞癌的进展。

期刊:Cell Death & Disease

影响因子:8.1

doi:10.1038/s41419-020-03040-5

Mengxian Tu,Lu He,Yang You,Jinying Li,Nan Yao,Chen Qu,Wei Huang,Leibo Xu,Rongcheng Luo,Jian Hong

NCOA5 deficiency promotes a unique liver protumorigenic microenvironment through p21WAF1/CIP1 overexpression, which is reversed by metformin

NCOA5 缺乏通过 p21WAF1/CIP1 过表达促进独特的肝脏致瘤微环境，而二甲双胍可逆转这一现象

期刊:Oncogene

影响因子:6.9

doi:10.1038/s41388-020-1256-x

Mark Williams #, Xinhui Liu #, Yueqi Zhang, Jake Reske, Devika Bahal, Trevor G Gohl, Daniel Hollern, Elliot Ensink, Matti Kiupel, Rongcheng Luo, Rupali Das, Hua Xiao

发表日期：2020

文献求助收藏

Positive feedback loop of FAM83A/PI3K/AKT/c-Jun induces migration, invasion and metastasis in hepatocellular carcinoma

FAM83A/PI3K/AKT/c-Jun正反馈回路诱导肝细胞癌迁移、侵袭和转移

期刊:Biomedicine & Pharmacotherapy

影响因子:6.9

doi:10.1016/j.biopha.2019.109780

Chen Liu, Xuemei Peng, Yonghao Li, Shu Liu, Rentao Hou, Yewei Zhang, Shi Zuo, Zhan Liu, Rongcheng Luo, Libo Li, Weiyi Fang

Curcumin inhibits cell proliferation and migration in NSCLC through a synergistic effect on the TLR4/MyD88 and EGFR pathways

姜黄素通过对TLR4/MyD88和EGFR通路产生协同作用，抑制非小细胞肺癌细胞的增殖和迁移。

期刊:Oncology Reports

影响因子:3.8

doi:10.3892/or.2019.7278

Lanfeng Zhang ,Xingyu Tao ,Qiaofen Fu ,Chunlei Ge ,Ruilei Li ,Zhen Li ,Ye Zhu ,Hui Tian ,Qiaolin Li ,Min Liu ,Hongyan Hu ,Baozhen Zeng ,Zhuyin Lin ,Chunyan Li ,Rongcheng Luo ,Xin Song

A cis-eQTL genetic variant in PLK4 confers high risk of hepatocellular carcinoma

PLK4 中的顺式 eQTL 基因变异赋予患肝细胞癌的高风险

期刊:Cancer Medicine

影响因子:2.9

doi:10.1002/cam4.2487

Lijuan Meng, Yan Zhou, Sihan Ju, Jing Han, Ci Song, Jing Kong, Yifei Wu, Shuai Lu, Jiani Xu, Wenwen Yuan, Erbao Zhang, Cheng Wang, Zhibin Hu, Yayun Gu, Rongcheng Luo, Xuehao Wang

HDGF and PRKCA upregulation is associated with a poor prognosis in patients with lung adenocarcinoma

HDGF 和 PRKCA 上调与肺腺癌患者预后不良相关

期刊:Oncology Letters

影响因子:2.5

doi:10.3892/ol.2019.10812

Honghong Jiang, Qiaofen Fu, Xin Song, Chunlei Ge, Ruilei Li, Zhen Li, Baozhen Zeng, Chunyan Li, Ying Wang, Yuanbo Xue, Rongcheng Luo, Weiyi Fang

MCM6 promotes metastasis of hepatocellular carcinoma via MEK/ERK pathway and serves as a novel serum biomarker for early recurrence

MCM6通过MEK/ERK通路促进肝细胞癌转移，并可作为早期复发的新型血清生物标志物。

期刊:Journal of Experimental & Clinical Cancer Research

影响因子:11.4

doi:10.1186/s13046-017-0669-z

Mingyu Liu,Qiaoting Hu,Mengxian Tu,Xinyi Wang,Zike Yang,Guoxiong Yang,Rongcheng Luo

FOXA1 inhibits hepatocellular carcinoma progression by suppressing PIK3R1 expression in male patients

FOXA1 通过抑制男性患者 PIK3R1 表达来抑制肝细胞癌进展

期刊:Journal of Experimental & Clinical Cancer Research

影响因子:11.4

doi:10.1186/s13046-017-0646-6

Shujiao He, Junyi Zhang, Wan Zhang, Fengsheng Chen, Rongcheng Luo

A single non-synonymous NCOA5 variation in type 2 diabetic patients with hepatocellular carcinoma impairs the function of NCOA5 in cell cycle regulation

患有肝细胞癌的 2 型糖尿病患者中单个非同义 NCOA5 变异会损害 NCOA5 在细胞周期调控中的作用

期刊:Cancer Letters

影响因子:9.1

doi:10.1016/j.canlet.2017.01.028

Xinhui Liu, Feiye Liu, Shenglan Gao, Jake Reske, Aimin Li, Chin-Lee Wu, Chengfeng Yang, Fengsheng Chen, Rongcheng Luo, Hua Xiao

Increased PA2G4 Expression Is an Unfavorable Factor in Nasopharyngeal Carcinoma

PA2G4 表达增高是鼻咽癌的不利因素

EFTUD2 maintains the survival of tumor cells and promotes hepatocellular carcinoma progression via the activation of STAT3

EFTUD2 通过激活 STAT3 来维持肿瘤细胞的存活并促进肝细胞癌的进展。

NCOA5 deficiency promotes a unique liver protumorigenic microenvironment through p21WAF1/CIP1 overexpression, which is reversed by metformin

NCOA5 缺乏通过 p21WAF1/CIP1 过表达促进独特的肝脏致瘤微环境，而二甲双胍可逆转这一现象

Positive feedback loop of FAM83A/PI3K/AKT/c-Jun induces migration, invasion and metastasis in hepatocellular carcinoma

FAM83A/PI3K/AKT/c-Jun正反馈回路诱导肝细胞癌迁移、侵袭和转移

Curcumin inhibits cell proliferation and migration in NSCLC through a synergistic effect on the TLR4/MyD88 and EGFR pathways

姜黄素通过对TLR4/MyD88和EGFR通路产生协同作用，抑制非小细胞肺癌细胞的增殖和迁移。

A cis-eQTL genetic variant in PLK4 confers high risk of hepatocellular carcinoma

PLK4 中的顺式 eQTL 基因变异赋予患肝细胞癌的高风险

HDGF and PRKCA upregulation is associated with a poor prognosis in patients with lung adenocarcinoma

HDGF 和 PRKCA 上调与肺腺癌患者预后不良相关

MCM6 promotes metastasis of hepatocellular carcinoma via MEK/ERK pathway and serves as a novel serum biomarker for early recurrence

MCM6通过MEK/ERK通路促进肝细胞癌转移，并可作为早期复发的新型血清生物标志物。

FOXA1 inhibits hepatocellular carcinoma progression by suppressing PIK3R1 expression in male patients

FOXA1 通过抑制男性患者 PIK3R1 表达来抑制肝细胞癌进展

A single non-synonymous NCOA5 variation in type 2 diabetic patients with hepatocellular carcinoma impairs the function of NCOA5 in cell cycle regulation

患有肝细胞癌的 2 型糖尿病患者中单个非同义 NCOA5 变异会损害 NCOA5 在细胞周期调控中的作用